Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
Asda warns of ‘difficult situation’ after US drugmaker Eli Lilly responds to pressure from Donald Trump
US pharmaceutical group ‘optimistic’ about reaching deal with British government
Trial results are a boost to US pharmaceutical company’s booming obesity business
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
US drugmaker wants changes to types of drugs approved in Britain
Danish pharma group seeks to broaden options and stay competitive with Eli Lilly
